Category Archives: competition

Health Tech and You Award Shortlist is Announced!

Posted on March 1, 2017 by Julia Manning

Partnered with AXA PPP healthcare and the Design Museum we are proud to announce the 2017 Health Tech and You Awards shortlist! Following the success of the previous two annual awards we have seen some of the best new forms … Continue reading →

Posted in competition, Global Health, Health and Wellbeing, NHS, Public Health | Tagged , , | Leave a comment

Keeping the Spirit of Bevan Alive

Posted on April 15, 2015 by Julia Manning

We are delighted to be able to report that nominations are now open for the Bevan Foundation’s third annual Bevan Prize for Health and Wellbeing. The Prize, which is sponsored by the Open University, UNISON and the Aneurin Bevan Society, … Continue reading →

Posted in competition, Health and Wellbeing | Tagged , , , , , , , , , | Leave a comment

Are pharmaceutical mega-mergers in the public interest?

Posted on May 2, 2014 by Barbara Arzymanow

The main reason for governments around the world to encourage the pharmaceutical industry is to support Research and Development –  R&D – with a view to the discovery of new drugs of future benefit to mankind. Commercial pharmaceutical companies have played … Continue reading →

Posted in Business, competition, Drugs, Innovation, International, Pharma, Policy, Research, Technology | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: Think carefully about value-based drug pricing in the UK and let common sense prevail.

Posted on September 20, 2012 by Barbara Arzymanow

David Cameron and Jeremy Hunt share an important skill. They both have firsts from Oxford in Politics, Philosophy and Economics (PPE). I am not the greatest fan of this course because I would like to see more scientists, engineers and … Continue reading →

Posted in Business, competition, David Cameron, Department of Health, Drugs, Election, Jeremy Hunt, NHS, Patients, Pharma, Policy, Primary Care | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: The NHS needs outstanding management as well as a legal framework, for example, to unlock the potential of the property portfolio.

Posted on April 20, 2012 by Barbara Arzymanow

The potential for improved efficiency in delivering effective healthcare within the framework of the Health and Social Care Act 2012 is enormous.  However, there will be no benefit without the management skills needed to take up the challenges. Many future … Continue reading →

Posted in CCGs, Commissioning, competition, Department of Health, Election, Employment, GPs, Health Bill, Health Team, Healthcare, Hospitals, Information, NHS, Nursing, Uncategorized | Tagged , , , , , , , , , , , , , , , | 2 Comments

Guest Blogspot: Pharmaceutical R & D – the value of radical innovation versus incremental progress

Posted on March 20, 2012 by Barbara Arzymanow

What we really want is affordable products that benefit patients, whether or not they are “innovative” in the usual sense of the word. Scientific innovation is not a medical end in itself. The ultimate aim of pharmaceutical R&D is to … Continue reading →

Posted in Business, competition, Department of Health, Drugs, Emerging technologies, Finance, Healthcare, Innovation, NHS, Patients, Pharma, Policy, Research, Technology, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

The Health and Social Care Bill: Final Stages in Parliament

Posted on February 21, 2012 by Barbara Arzymanow

With opposition to the Health and Social Care Bill having reached new heights, we must look behind the rhetoric and remember basic principles. The most important point to remember is that the NHS exists to provide the best possible, affordable … Continue reading →

Posted in Andrew Lansley, Business, Commissioning, competition, David Cameron, Department of Health, GPs, Health Bill, Hospitals, Inequality, NHS, Patient choice, Patients | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Guest Blogspot: Misleading, Biased Reporting on the Health and Social Care Bill in the Media

Posted on January 18, 2012 by Barbara Arzymanow

Above all the freedom of the Press is paramount. Censorship or severely restrictive legislation is not an acceptable alternative. We sometimes have to accept the consequences and tolerate a Press that can be wrong, unfair, misleading or more interested in … Continue reading →

Posted in Andrew Lansley, competition, David Cameron, Department of Health, equality, Finance, Health Bill, Hospitals, Inequality, NHS, Patients, Private | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , | 6 Comments

Patients to access their own medical records by 2015

Posted on December 2, 2011 by samantha2020

Earlier this week during the chancellor of the exchequer’s autumn financial statement, it was announced that not only will patients have online access to their medical records from 2015, but they will be able to see data on GP performance … Continue reading →

Posted in Andrew Lansley, competition, Information, Policy | Tagged , , , | Leave a comment

Parallel importing and exporting of pharmaceuticals severely limits the options in designing an effective UK drug pricing scheme.

Posted on November 15, 2011 by Barbara Arzymanow

A fundamental principle of the EU is the establishment of a single market where products can be freely imported and exported between member states. In the case of pharmaceuticals this ideal conflicts with the freedom of individual countries to fix … Continue reading →

Posted in Business, competition, Department of Health, Drugs, Innovation, NHS, Pharma, Policy, Research | Tagged , , , , , , , , , , , , , , , , , , , , , | 1 Comment